Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 73 to 81 of 81 entries
Sorted by: Best Match Show Resources per page
Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel.

JNCI cancer spectrum

Halabi S, Dutta S, Tangen CM, Rosenthal M, Petrylak DP, Thompson IM, Chi KN, De Bono JS, Araujo JC, Logothetis C, Eisenberger MA, Quinn DI, Fizazi K, Morris MJ, Higano CS, Tannock IF, Small EJ, Kelly WK.
PMID: 32368717
JNCI Cancer Spectr. 2020 Jan 29;4(2):pkaa003. doi: 10.1093/jncics/pkaa003. eCollection 2020 Apr.

There are few data regarding disparities in overall survival (OS) between Asian and white men with metastatic castration-resistant prostate cancer (mCRPC). We compared OS of Asian and white mCRPC men treated in phase III clinical trials with docetaxel and...

Cite
Halabi S, Dutta S, Tangen CM, et al. Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel. JNCI Cancer Spectr. 2020;4(2):pkaa003doi: 10.1093/jncics/pkaa003.
Halabi, S., Dutta, S., Tangen, C. M., Rosenthal, M., Petrylak, D. P., Thompson, I. M., Chi, K. N., De Bono, J. S., Araujo, J. C., Logothetis, C., Eisenberger, M. A., Quinn, D. I., Fizazi, K., Morris, M. J., Higano, C. S., Tannock, I. F., Small, E. J., & Kelly, W. K. (2020). Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel. JNCI cancer spectrum, 4(2), pkaa003. https://doi.org/10.1093/jncics/pkaa003
Halabi, Susan, et al. "Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel." JNCI cancer spectrum vol. 4,2 (2020): pkaa003. doi: https://doi.org/10.1093/jncics/pkaa003
Halabi S, Dutta S, Tangen CM, Rosenthal M, Petrylak DP, Thompson IM, Chi KN, De Bono JS, Araujo JC, Logothetis C, Eisenberger MA, Quinn DI, Fizazi K, Morris MJ, Higano CS, Tannock IF, Small EJ, Kelly WK. Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel. JNCI Cancer Spectr. 2020 Jan 29;4(2):pkaa003. doi: 10.1093/jncics/pkaa003. eCollection 2020 Apr. PMID: 32368717; PMCID: PMC7190204.
Copy Download .nbib Format: NLM
Effect of Sodium Taurocholate on the In Vitro Growth of Lactobacilli.

Microbial ecology

Tannock GW, Bateup JM, Jenkinson HF.
PMID: 9052650
Microb Ecol. 1997 Mar;33(2):163-7. doi: 10.1007/s002489900018.

No abstract available.

Cite
Tannock GW, Bateup JM, Jenkinson HF. Effect of Sodium Taurocholate on the In Vitro Growth of Lactobacilli. Microb Ecol. 1997;33(2):163-7doi: 10.1007/s002489900018.
Tannock, G. W., Bateup, J. M., & Jenkinson, H. F. (1997). Effect of Sodium Taurocholate on the In Vitro Growth of Lactobacilli. Microbial ecology, 33(2), 163-7. https://doi.org/10.1007/s002489900018
Tannock, et al. "Effect of Sodium Taurocholate on the In Vitro Growth of Lactobacilli." Microbial ecology vol. 33,2 (1997): 163-7. doi: https://doi.org/10.1007/s002489900018
Tannock GW, Bateup JM, Jenkinson HF. Effect of Sodium Taurocholate on the In Vitro Growth of Lactobacilli. Microb Ecol. 1997 Mar;33(2):163-7. doi: 10.1007/s002489900018. PMID: 9052650.
Copy Download .nbib Format: NLM
Science and technology roadmap for graphene, related two-dimensional crystals, and hybrid systems.

Nanoscale

Ferrari AC, Bonaccorso F, Fal'ko V, Novoselov KS, Roche S, Bøggild P, Borini S, Koppens FH, Palermo V, Pugno N, Garrido JA, Sordan R, Bianco A, Ballerini L, Prato M, Lidorikis E, Kivioja J, Marinelli C, Ryhänen T, Morpurgo A, Coleman JN, Nicolosi V, Colombo L, Fert A, Garcia-Hernandez M, Bachtold A, Schneider GF, Guinea F, Dekker C, Barbone M, Sun Z, Galiotis C, Grigorenko AN, Konstantatos G, Kis A, Katsnelson M, Vandersypen L, Loiseau A, Morandi V, Neumaier D, Treossi E, Pellegrini V, Polini M, Tredicucci A, Williams GM, Hong BH, Ahn JH, Kim JM, Zirath H, van Wees BJ, van der Zant H, Occhipinti L, Di Matteo A, Kinloch IA, Seyller T, Quesnel E, Feng X, Teo K, Rupesinghe N, Hakonen P, Neil SR, Tannock Q, Löfwander T, Kinaret J.
PMID: 25707682
Nanoscale. 2015 Mar 21;7(11):4598-810. doi: 10.1039/c4nr01600a.

We present the science and technology roadmap for graphene, related two-dimensional crystals, and hybrid systems, targeting an evolution in technology, that might lead to impacts and benefits reaching into most areas of society. This roadmap was developed within the...

Cite
Ferrari AC, Bonaccorso F, Fal'ko V, et al. Science and technology roadmap for graphene, related two-dimensional crystals, and hybrid systems. Nanoscale. 2015;7(11):4598-810doi: 10.1039/c4nr01600a.
Ferrari, A. C., Bonaccorso, F., Fal'ko, V., Novoselov, K. S., Roche, S., Bøggild, P., Borini, S., Koppens, F. H., Palermo, V., Pugno, N., Garrido, J. A., Sordan, R., Bianco, A., Ballerini, L., Prato, M., Lidorikis, E., Kivioja, J., Marinelli, C., Ryhänen, T., Morpurgo, A., Coleman, J. N., Nicolosi, V., Colombo, L., Fert, A., Garcia-Hernandez, M., Bachtold, A., Schneider, G. F., Guinea, F., Dekker, C., Barbone, M., Sun, Z., Galiotis, C., Grigorenko, A. N., Konstantatos, G., Kis, A., Katsnelson, M., Vandersypen, L., Loiseau, A., Morandi, V., Neumaier, D., Treossi, E., Pellegrini, V., Polini, M., Tredicucci, A., Williams, G. M., Hong, B. H., Ahn, J. H., Kim, J. M., Zirath, H., van Wees, B. J., van der Zant, H., Occhipinti, L., Di Matteo, A., Kinloch, I. A., Seyller, T., Quesnel, E., Feng, X., Teo, K., Rupesinghe, N., Hakonen, P., Neil, S. R., Tannock, Q., Löfwander, T., & Kinaret, J. (2015). Science and technology roadmap for graphene, related two-dimensional crystals, and hybrid systems. Nanoscale, 7(11), 4598-810. https://doi.org/10.1039/c4nr01600a
Ferrari, Andrea C, et al. "Science and technology roadmap for graphene, related two-dimensional crystals, and hybrid systems." Nanoscale vol. 7,11 (2015): 4598-810. doi: https://doi.org/10.1039/c4nr01600a
Ferrari AC, Bonaccorso F, Fal'ko V, Novoselov KS, Roche S, Bøggild P, Borini S, Koppens FH, Palermo V, Pugno N, Garrido JA, Sordan R, Bianco A, Ballerini L, Prato M, Lidorikis E, Kivioja J, Marinelli C, Ryhänen T, Morpurgo A, Coleman JN, Nicolosi V, Colombo L, Fert A, Garcia-Hernandez M, Bachtold A, Schneider GF, Guinea F, Dekker C, Barbone M, Sun Z, Galiotis C, Grigorenko AN, Konstantatos G, Kis A, Katsnelson M, Vandersypen L, Loiseau A, Morandi V, Neumaier D, Treossi E, Pellegrini V, Polini M, Tredicucci A, Williams GM, Hong BH, Ahn JH, Kim JM, Zirath H, van Wees BJ, van der Zant H, Occhipinti L, Di Matteo A, Kinloch IA, Seyller T, Quesnel E, Feng X, Teo K, Rupesinghe N, Hakonen P, Neil SR, Tannock Q, Löfwander T, Kinaret J. Science and technology roadmap for graphene, related two-dimensional crystals, and hybrid systems. Nanoscale. 2015 Mar 21;7(11):4598-810. doi: 10.1039/c4nr01600a. PMID: 25707682.
Copy Download .nbib Format: NLM
Making Sense of Muscle Protein Synthesis: A Focus on Muscle Growth During Resistance Training.

International journal of sport nutrition and exercise metabolism

Witard OC, Bannock L, Tipton KD.
PMID: 34697259
Int J Sport Nutr Exerc Metab. 2021 Oct 25;1-13. doi: 10.1123/ijsnem.2021-0139. Epub 2021 Oct 25.

The acute response of muscle protein synthesis (MPS) to resistance exercise and nutrition is often used to inform recommendations for exercise programming and dietary interventions, particularly protein nutrition, to support and enhance muscle growth with training. Those recommendations are...

Cite
Witard OC, Bannock L, Tipton KD. Making Sense of Muscle Protein Synthesis: A Focus on Muscle Growth During Resistance Training. Int J Sport Nutr Exerc Metab. 2021;1-13doi: 10.1123/ijsnem.2021-0139.
Witard, O. C., Bannock, L., & Tipton, K. D. (2021). Making Sense of Muscle Protein Synthesis: A Focus on Muscle Growth During Resistance Training. International journal of sport nutrition and exercise metabolism, 1-13. https://doi.org/10.1123/ijsnem.2021-0139
Witard, Oliver C, et al. "Making Sense of Muscle Protein Synthesis: A Focus on Muscle Growth During Resistance Training." International journal of sport nutrition and exercise metabolism vol. (2021): 1-13. doi: https://doi.org/10.1123/ijsnem.2021-0139
Witard OC, Bannock L, Tipton KD. Making Sense of Muscle Protein Synthesis: A Focus on Muscle Growth During Resistance Training. Int J Sport Nutr Exerc Metab. 2021 Oct 25;1-13. doi: 10.1123/ijsnem.2021-0139. Epub 2021 Oct 25. PMID: 34697259.
Copy Download .nbib Format: NLM
Neural processing of working memory in adults with ADHD in a visuospatial change detection task with distractors.

PeerJ

Gu C, Liu ZX, Tannock R, Woltering S.
PMID: 30245935
PeerJ. 2018 Sep 18;6:e5601. doi: 10.7717/peerj.5601. eCollection 2018.

Individuals with Attention-Deficit Hyperactivity Disorder (ADHD) are often characterized by deficits in working memory (WM), which manifest in academic, professional, and mental health difficulties. To better understand the underlying mechanisms of these presumed WM deficits, we compared adults with...

Cite
Gu C, Liu ZX, Tannock R, et al. Neural processing of working memory in adults with ADHD in a visuospatial change detection task with distractors. PeerJ. 2018;6:e5601doi: 10.7717/peerj.5601.
Gu, C., Liu, Z. X., Tannock, R., & Woltering, S. (2018). Neural processing of working memory in adults with ADHD in a visuospatial change detection task with distractors. PeerJ, 6e5601. https://doi.org/10.7717/peerj.5601
Gu, Chao, et al. "Neural processing of working memory in adults with ADHD in a visuospatial change detection task with distractors." PeerJ vol. 6 (2018): e5601. doi: https://doi.org/10.7717/peerj.5601
Gu C, Liu ZX, Tannock R, Woltering S. Neural processing of working memory in adults with ADHD in a visuospatial change detection task with distractors. PeerJ. 2018 Sep 18;6:e5601. doi: 10.7717/peerj.5601. eCollection 2018. PMID: 30245935; PMCID: PMC6149497.
Copy Download .nbib Format: NLM
Predictors Linking Obesity and the Gut Microbiome (the PROMISE Study): Protocol and Recruitment Strategy for a Cross-Sectional Study on Pathways That Affect the Gut Microbiome and Its Impact on Obesity.

JMIR research protocols

Kindleysides S, Kruger R, Douwes J, Tannock GW, Renall N, Slater J, Lawley B, McGill AT, Brennan N, Manukia M, Richter M, Tupai-Firestone R, Signal TL, Gander P, Stannard SR, Breier BH.
PMID: 31452525
JMIR Res Protoc. 2019 Aug 26;8(8):e14529. doi: 10.2196/14529.

BACKGROUND: The prevalence of obesity has increased substantially over recent decades and is associated with considerable health inequalities. Although the causes of obesity are complex, key drivers include overconsumption of highly palatable, energy-dense, and nutrient-poor foods, which have a...

Cite
Kindleysides S, Kruger R, Douwes J, et al. Predictors Linking Obesity and the Gut Microbiome (the PROMISE Study): Protocol and Recruitment Strategy for a Cross-Sectional Study on Pathways That Affect the Gut Microbiome and Its Impact on Obesity. JMIR Res Protoc. 2019;8(8):e14529doi: 10.2196/14529.
Kindleysides, S., Kruger, R., Douwes, J., Tannock, G. W., Renall, N., Slater, J., Lawley, B., McGill, A. T., Brennan, N., Manukia, M., Richter, M., Tupai-Firestone, R., Signal, T. L., Gander, P., Stannard, S. R., & Breier, B. H. (2019). Predictors Linking Obesity and the Gut Microbiome (the PROMISE Study): Protocol and Recruitment Strategy for a Cross-Sectional Study on Pathways That Affect the Gut Microbiome and Its Impact on Obesity. JMIR research protocols, 8(8), e14529. https://doi.org/10.2196/14529
Kindleysides, Sophie, et al. "Predictors Linking Obesity and the Gut Microbiome (the PROMISE Study): Protocol and Recruitment Strategy for a Cross-Sectional Study on Pathways That Affect the Gut Microbiome and Its Impact on Obesity." JMIR research protocols vol. 8,8 (2019): e14529. doi: https://doi.org/10.2196/14529
Kindleysides S, Kruger R, Douwes J, Tannock GW, Renall N, Slater J, Lawley B, McGill AT, Brennan N, Manukia M, Richter M, Tupai-Firestone R, Signal TL, Gander P, Stannard SR, Breier BH. Predictors Linking Obesity and the Gut Microbiome (the PROMISE Study): Protocol and Recruitment Strategy for a Cross-Sectional Study on Pathways That Affect the Gut Microbiome and Its Impact on Obesity. JMIR Res Protoc. 2019 Aug 26;8(8):e14529. doi: 10.2196/14529. PMID: 31452525; PMCID: PMC6732966.
Copy Download .nbib Format: NLM
Avoiding the hazards of misinterpreting treatment effects.

Annals of oncology : official journal of the European Society for Medical Oncology

Saad ED, Tannock IF.
PMID: 30346470
Ann Oncol. 2019 Jan 01;30(1):16-18. doi: 10.1093/annonc/mdy472.

No abstract available.

Cite
Saad ED, Tannock IF. Avoiding the hazards of misinterpreting treatment effects. Ann Oncol. 2019;30(1):16-18doi: 10.1093/annonc/mdy472.
Saad, E. D., & Tannock, I. F. (2019). Avoiding the hazards of misinterpreting treatment effects. Annals of oncology : official journal of the European Society for Medical Oncology, 30(1), 16-18. https://doi.org/10.1093/annonc/mdy472
Saad, E D, and Tannock, I F. "Avoiding the hazards of misinterpreting treatment effects." Annals of oncology : official journal of the European Society for Medical Oncology vol. 30,1 (2019): 16-18. doi: https://doi.org/10.1093/annonc/mdy472
Saad ED, Tannock IF. Avoiding the hazards of misinterpreting treatment effects. Ann Oncol. 2019 Jan 01;30(1):16-18. doi: 10.1093/annonc/mdy472. PMID: 30346470.
Copy Download .nbib Format: NLM
Updating Reports of Phase 3 Clinical Trials for Cancer.

JAMA oncology

Elimova E, Moignard S, Li X, Yu M, Xu W, Seruga B, Tannock IF.
PMID: 33538777
JAMA Oncol. 2021 Apr 01;7(4):593-596. doi: 10.1001/jamaoncol.2020.6968.

IMPORTANCE: Phase 3 randomized clinical trials (RCTs) are usually reported after a predetermined number of events (death or disease progression) have occurred, when survival curves remain poorly defined. Updated reports are important in providing mature data.OBJECTIVES: To evaluate the...

Cite
Elimova E, Moignard S, Li X, et al. Updating Reports of Phase 3 Clinical Trials for Cancer. JAMA Oncol. 2021;7(4):593-596doi: 10.1001/jamaoncol.2020.6968.
Elimova, E., Moignard, S., Li, X., Yu, M., Xu, W., Seruga, B., & Tannock, I. F. (2021). Updating Reports of Phase 3 Clinical Trials for Cancer. JAMA oncology, 7(4), 593-596. https://doi.org/10.1001/jamaoncol.2020.6968
Elimova, Elena, et al. "Updating Reports of Phase 3 Clinical Trials for Cancer." JAMA oncology vol. 7,4 (2021): 593-596. doi: https://doi.org/10.1001/jamaoncol.2020.6968
Elimova E, Moignard S, Li X, Yu M, Xu W, Seruga B, Tannock IF. Updating Reports of Phase 3 Clinical Trials for Cancer. JAMA Oncol. 2021 Apr 01;7(4):593-596. doi: 10.1001/jamaoncol.2020.6968. PMID: 33538777; PMCID: PMC7863013.
Copy Download .nbib Format: NLM
Adjuvant Zoledronate Therapy for Women With Breast Cancer-Effective Treatment or Fool's Gold?.

JAMA oncology

Desnoyers A, Amir E, Tannock IF.
PMID: 34165515
JAMA Oncol. 2021 Aug 01;7(8):1121-1123. doi: 10.1001/jamaoncol.2021.1516.

No abstract available.

Cite
Desnoyers A, Amir E, Tannock IF. Adjuvant Zoledronate Therapy for Women With Breast Cancer-Effective Treatment or Fool's Gold?. JAMA Oncol. 2021;7(8):1121-1123doi: 10.1001/jamaoncol.2021.1516.
Desnoyers, A., Amir, E., & Tannock, I. F. (2021). Adjuvant Zoledronate Therapy for Women With Breast Cancer-Effective Treatment or Fool's Gold?. JAMA oncology, 7(8), 1121-1123. https://doi.org/10.1001/jamaoncol.2021.1516
Desnoyers, Alexandra, et al. "Adjuvant Zoledronate Therapy for Women With Breast Cancer-Effective Treatment or Fool's Gold?." JAMA oncology vol. 7,8 (2021): 1121-1123. doi: https://doi.org/10.1001/jamaoncol.2021.1516
Desnoyers A, Amir E, Tannock IF. Adjuvant Zoledronate Therapy for Women With Breast Cancer-Effective Treatment or Fool's Gold?. JAMA Oncol. 2021 Aug 01;7(8):1121-1123. doi: 10.1001/jamaoncol.2021.1516. PMID: 34165515.
Copy Download .nbib Format: NLM
Showing 73 to 81 of 81 entries